BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:14 PM
 | 
May 05, 2010
 |  BC Extra  |  Company News

Boehringer, Micromet in cancer deal

Boehringer Ingelheim GmbH (Ingelheim, Germany) and Micromet Inc. (NASDAQ:MITI) partnered to develop and commercialize a bispecific T cell engager (BiTE) antibody to treat...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >